Delivery Order SPE2DB24D2010-SPE2DB25FZYL3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,735.09 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Prolia 60 mg/ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award under the company's existing pharmaceutical supply framework with the federal government. This...
- The Defense Logistics Agency awarded a $26,034.19 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes under a firm fixed-price contract. The delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $61,057.84 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prolia 60 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a $10,746.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Prolia 60 mg/ml syringes. The contract, designated as a non-set-aside competitive award, is scheduled for ultimate completion by April 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.96 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,113.51 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader relationship with the federal government as a major...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prolia 60 mg/mL syringes valued at $45,690.24. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and was awarded without set-aside provisions through competitive procurement. The awardee, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.14 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order, awarded on September 16, 2025, represents a non-competitive, non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Prolia 60 mg/mL syringes, valued at $11,629.70. This is a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,697.68 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued under...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZYL3Delivery Order
The Defense Logistics Agency awarded a $14,574.17 delivery order to AmerisourceBergen Drug Corp on May 7, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by May 8, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's critical role in supporting federal pharmaceutical procurement for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 5/7/25 |